210 related articles for article (PubMed ID: 17933720)
1. Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors.
Arastéh K; Stocker H
Eur J Med Res; 2007 Oct; 12(9):397-402. PubMed ID: 17933720
[TBL] [Abstract][Full Text] [Related]
2. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
3. Determination of HIV-1 coreceptor tropism in clinical practise.
Foeglein A; Walter H
Eur J Med Res; 2007 Oct; 12(9):473-82. PubMed ID: 17933729
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of HIV coreceptor tropism.
Hoffmann C
Eur J Med Res; 2007 Oct; 12(9):385-90. PubMed ID: 17933718
[TBL] [Abstract][Full Text] [Related]
5. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
6. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
7. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines.
Ito Y; Grivel JC; Chen S; Kiselyeva Y; Reichelderfer P; Margolis L
J Infect Dis; 2004 Feb; 189(3):506-14. PubMed ID: 14745709
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.
Moyle GJ; Wildfire A; Mandalia S; Mayer H; Goodrich J; Whitcomb J; Gazzard BG
J Infect Dis; 2005 Mar; 191(6):866-72. PubMed ID: 15717260
[TBL] [Abstract][Full Text] [Related]
9. CCR5 antagonists: a new tool in fighting HIV.
Jülg B; Goebel FD
J HIV Ther; 2005 Dec; 10(4):68-71. PubMed ID: 16519245
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
[TBL] [Abstract][Full Text] [Related]
11. HIV coreceptor phenotyping in the clinical setting.
Low AJ; Swenson LC; Harrigan PR
AIDS Rev; 2008; 10(3):143-51. PubMed ID: 18820716
[TBL] [Abstract][Full Text] [Related]
12. Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4.
Owen A; Chandler B; Bray PG; Ward SA; Hart CA; Back DJ; Khoo SH
J Virol; 2004 Nov; 78(21):12022-9. PubMed ID: 15479841
[TBL] [Abstract][Full Text] [Related]
13. Pouncing on the chemokine receptor Chimera.
Mascolini M
J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):13-24. PubMed ID: 11364629
[TBL] [Abstract][Full Text] [Related]
14. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6.
Grivel JC; Ito Y; Fagà G; Santoro F; Shaheen F; Malnati MS; Fitzgerald W; Lusso P; Margolis L
Nat Med; 2001 Nov; 7(11):1232-5. PubMed ID: 11689888
[TBL] [Abstract][Full Text] [Related]
15. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
Princen K; Schols D
Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
[TBL] [Abstract][Full Text] [Related]
16. Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses.
Wolinsky SM; Veazey RS; Kunstman KJ; Klasse PJ; Dufour J; Marozsan AJ; Springer MS; Moore JP
Virology; 2004 Oct; 328(1):19-29. PubMed ID: 15380354
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
[TBL] [Abstract][Full Text] [Related]
18. Maraviroc: new drug. Multiple antiretroviral treatment failure: too soon to reach conclusions.
Prescrire Int; 2008 Jun; 17(95):98-101. PubMed ID: 18623908
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
Hirsch MS; Günthard HF; Schapiro JM; Brun-Vézinet F; Clotet B; Hammer SM; Johnson VA; Kuritzkes DR; Mellors JW; Pillay D; Yeni PG; Jacobsen DM; Richman DD
Clin Infect Dis; 2008 Jul; 47(2):266-85. PubMed ID: 18549313
[TBL] [Abstract][Full Text] [Related]
20. [CCR5 antagonists: a new class of antiretrovirals].
Peytavin G; Calvez V; Katlama C
Therapie; 2009; 64(1):9-16. PubMed ID: 19463248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]